Temple RM - Search Results

1

Recombinant erythropoietin improves cognitive function in chronic haemodialysis patients.

Temple RM, Langan SJ, Deary IJ, Winney RJ. Temple RM, et al. Nephrol Dial Transplant. 1992;7(3):240-5. doi: 10.1093/oxfordjournals.ndt.a092113. Nephrol Dial Transplant. 1992. PMID: 1314997

2

Effect of treatment mode on the natural history of acquired cystic disease of the kidney in patients on renal replacement therapy.

Jenkins DA, Temple RM, Winney RJ, Allan PL, Notgi A, Wild SR. Jenkins DA, et al. Among authors: temple rm. Nephrol Dial Transplant. 1992;7(7):613-7. doi: 10.1093/ndt/7.7.613. Nephrol Dial Transplant. 1992. PMID: 1323071

3

Recombinant erythropoietin improves cognitive function in patients maintained on chronic ambulatory peritoneal dialysis.

Temple RM, Deary IJ, Winney RJ. Temple RM, et al. Nephrol Dial Transplant. 1995;10(9):1733-8. Nephrol Dial Transplant. 1995. PMID: 8559497 Clinical Trial.

4

The disposition of paracetamol and the accumulation of its glucuronide and sulphate conjugates during multiple dosing in patients with chronic renal failure.

Martin U, Temple RM, Winney RJ, Prescott LF. Martin U, et al. Among authors: temple rm. Eur J Clin Pharmacol. 1991;41(1):43-6. doi: 10.1007/BF00280104. Eur J Clin Pharmacol. 1991. PMID: 1782975

5

Paracetamol disposition and metabolite kinetics in patients with chronic renal failure.

Prescott LF, Speirs GC, Critchley JA, Temple RM, Winney RJ. Prescott LF, et al. Among authors: temple rm. Eur J Clin Pharmacol. 1989;36(3):291-7. doi: 10.1007/BF00558162. Eur J Clin Pharmacol. 1989. PMID: 2744070

6

The disposition of paracetamol and its conjugates during multiple dosing in patients with end-stage renal failure maintained on haemodialysis.

Martin U, Temple RM, Winney RJ, Prescott LF. Martin U, et al. Among authors: temple rm. Eur J Clin Pharmacol. 1993;45(2):141-5. doi: 10.1007/BF00315495. Eur J Clin Pharmacol. 1993. PMID: 8223835

7

Seizure related to erythropoietin treatment in patients undergoing dialysis.

Temple RM, Eadington DW, Swainson CP, Winney R. Temple RM, et al. BMJ. 1990 Jan 6;300(6716):46. doi: 10.1136/bmj.300.6716.46-a. BMJ. 1990. PMID: 2105131 Free PMC article. No abstract available.

8

Is early treatment of anaemia with epoetin-alpha beneficial to pre-dialysis chronic kidney disease patients? Results of a multicentre, open-label, prospective, randomized, comparative group trial.

Macdougall IC, Temple RM, Kwan JT. Macdougall IC, et al. Among authors: temple rm. Nephrol Dial Transplant. 2007 Mar;22(3):784-93. doi: 10.1093/ndt/gfl483. Epub 2006 Sep 12. Nephrol Dial Transplant. 2007. PMID: 16968726 Clinical Trial.

9

Does community-wide chronic kidney disease management improve patient outcomes?

Rayner HC, Baharani J, Dasgupta I, Suresh V, Temple RM, Thomas ME, Smith SA. Rayner HC, et al. Among authors: temple rm. Nephrol Dial Transplant. 2014 Mar;29(3):644-9. doi: 10.1093/ndt/gft486. Epub 2013 Dec 10. Nephrol Dial Transplant. 2014. PMID: 24335381

10

The Acute Kidney Outreach to Prevent Deterioration and Death trial: a large pilot study for a cluster-randomized trial.

Thomas ME, Abdelaziz TS, Perkins GD, Sitch AJ, Baharani J, Temple RM. Thomas ME, et al. Among authors: temple rm. Nephrol Dial Transplant. 2021 Mar 29;36(4):657-665. doi: 10.1093/ndt/gfz246. Nephrol Dial Transplant. 2021. PMID: 31860096 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters